List Of Schedule 3 Medications
The following is a list of the most commonly encountered drugs currently controlled under the misuse of drugs legislation showing their respective classifications under both the Misuse of Drugs. The Oregon State Board of Pharmacy (OSBP) also maintains a list of controlled and 3. Examples of Schedule 4 medications include alprazolam (Xanax). POISONS STANDARD 2009 The National Drugs and Poisons iii. Schedule 1-Standard for the. Uniform Scheduling of Drugs and Poisons No..
This is the list of Schedule I drugs as defined by the United StatesControlled Substances Act.[1] The following findings are required for drugs to be placed in this schedule:[2]
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision.
Except as specifically authorized, it is illegal for any person:
- to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or
- to create, distribute, or dispense, or possess with intent to distribute or dispense, a counterfeit substance.[3]
The complete list of Schedule I drugs follows.[1] The Administrative Controlled Substances Code Number for each drug is included.
Opioids[edit]
ACSCN | Drug |
---|---|
9815 | Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) |
9601 | Acetylmethadol |
9602 | Allylprodine |
9603 | Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) |
9604 | Alphameprodine |
9605 | Alphamethadol |
9814 | Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) |
9832 | Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) |
9606 | Benzethidine |
9607 | Betacetylmethadol |
9830 | Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide) |
9831 | Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide |
9608 | Betameprodine |
9609 | Betamethadol |
9611 | Betaprodine |
9612 | Clonitazene |
9613 | Dextromoramide |
9615 | Diampromide |
9616 | Diethylthiambutene |
9168 | Difenoxin |
9617 | Dimenoxadol |
9618 | Dimepheptanol |
9619 | Dimethylthiambutene |
9621 | Dioxaphetyl butyrate |
9622 | Dipipanone |
9623 | Ethylmethylthiambutene |
9624 | Etonitazene |
9625 | Etoxeridine |
9626 | Furethidine |
9627 | Hydroxypethidine |
9628 | Ketobemidone |
9629 | Levomoramide |
9631 | Levophenacylmorphan |
9813 | 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
9833 | 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
9632 | Morpheridine |
9661 | MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) |
9633 | Noracymethadol |
9634 | Norlevorphanol |
9635 | Normethadone |
9636 | Norpipanone |
9812 | Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide |
9663 | PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine |
9637 | Phenadoxone |
9638 | Phenampromide |
9647 | Phenomorphan |
9641 | Phenoperidine |
9642 | Piritramide |
9643 | Proheptazine |
9644 | Properidine |
9649 | Propiram |
9645 | Racemoramide |
9835 | Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide |
9750 | Tilidine |
9646 | Trimeperidine |
9821 | Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)[4] |
Opium derivatives[edit]
ACSCN | Drug |
---|---|
9319 | Acetorphine |
9051 | Acetyldihydrocodeine |
9052 | Benzylmorphine |
9070 | Codeine methylbromide |
9053 | Codeine-N-Oxide |
9054 | Cyprenorphine |
9055 | Desomorphine |
9145 | Dihydromorphine |
9335 | Drotebanol |
9056 | Etorphine (except hydrochloride salt) |
9200 | Heroin (diacetylmorphine) |
9301 | Hydromorphinol |
9302 | Methyldesorphine |
9304 | Methyldihydromorphine |
9305 | Morphine methylbromide |
9306 | Morphine methylsulfonate |
9307 | Morphine-N-Oxide |
9308 | Myrophine |
9309 | Nicocodeine |
9312 | Nicomorphine |
9313 | Normorphine |
9314 | Pholcodine |
9315 | Thebacon |
Hallucinogenic or psychedelic substances[edit]
ACSCN | Drug |
---|---|
7249 | Alpha-Ethyltryptamine (αET) |
7391 | 4-bromo-2,5-dimethoxy-amphetamine (DOB) |
7392 | 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) |
7396 | 2,5-dimethoxyamphetamine (DOA) |
7399 | 2,5-Dimethoxy-4-ethylamphetamine (DOE) |
7348 | 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of isomers |
7411 | 4-methoxyamphetamine (PMA) |
7401 | 5-methoxy-3,4-methylenedioxyamphetamine (MMDA) |
7395 | 4-methyl-2,5-dimethoxyamphetamine (DOM; STP) |
7400 | 3,4-methylenedioxyamphetamine (MDA, Sassafrass) |
7405 | 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy, Molly) |
7404 | 3,4-methylenedioxy-N-ethylamphetamine (MDEA; MDE) |
7402 | N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA) |
7390 | 3,4,5-trimethoxyamphetamine (TMA) |
7431 | 5-methoxy-N,N-dimethyltryptamine (5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT) |
7432 | Alpha-methyltryptamine (αMT) |
7433 | Bufotenine |
7434 | Diethyltryptamine (DET) |
7435 | Dimethyltryptamine (DMT) |
7439 | 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers |
7260 | Ibogaine |
7315 | Lysergic acid diethylamide (LSD) |
7360 | Marijuana or hemp, including cannabis resin |
7350 | Marijuana extracts; hemp extracts; cannabinoids[5] |
7381 | Mescaline |
7374 | Parahexyl |
7415 | Peyote |
7482 | N-ethyl-3-piperidyl benzilate |
7484 | N-methyl-3-piperidyl benzilate |
7437 | Psilocybin |
7438 | Psilocin |
7370 | Tetrahydrocannabinol (THC) |
7455 | Ethylamine analog of phencyclidine (Eticyclidine; PCE) |
7458 | Pyrrolidine analog of phencyclidine (PCPy) |
7470 | Thiophene analog of phencyclidine (TCP) |
7473 | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (TCPy) |
1248 | 4-methylmethcathinone (Mephedrone) |
7535 | 3,4-methylenedioxypyrovalerone (MDPV) |
7509 | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) |
7508 | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) |
7519 | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) |
7518 | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) |
7385 | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) |
7532 | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) |
7517 | 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) |
7521 | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) |
7524 | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) |
7540 | 3,4-Methylenedioxy-N-methylcathinone (Methylone) |
Depressants[edit]
ACSCN | Drug |
---|---|
2010 | gamma-Hydroxybutyric acid (GHB; sodium oxybate; sodium oxybutyrate) except formulations in an FDA-approved drug product are Schedule III |
2572 | Mecloqualone |
2565 | Methaqualone |
Stimulants[edit]
ACSCN | Drug |
---|---|
1585 | Aminorex (aminoxaphen; 2-amino-5-phenyl-2- oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) |
7493 | N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers |
1235 | Cathinone |
1503 | Fenethylline |
1237 | Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers |
1590 | (+/-)cis-4-methylaminorex |
1475 | N-ethylamphetamine |
1480 | N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) |
Cannabimimetic agents[edit]
ACSCN | Drug |
---|---|
7297 | 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) |
7298 | 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) |
7118 | 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) |
7173 | 1-butyl-3-(1-naphthoyl)indole (JWH-073) |
7019 | 1-hexyl-3-(1-naphthoyl)indole (JWH-019) |
7200 | 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) |
6250 | 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) |
7081 | 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) |
7122 | 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
7398 | 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
7201 | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) |
7694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) |
7104 | 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) |
7008 | 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8) |
7203 | 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
Temporary/emergency listings[edit]
These items are listed by the Secretary of Health and Human Services pursuant to 21 CFR 1308.49.[6][7]
ACSCN | Drug |
---|---|
7144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
7011 | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
7048 | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA, AKB-48) |
7222 | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC, PB-22)[8] |
7225 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)[8] |
7012 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)[8] |
7035 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)[8] |
7031 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)[9] |
7023 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)[9] |
7024 | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)[9] |
7538 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)[10] |
7537 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)[10] |
7536 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)[10] |
9547 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]N-methylbenzamide) (U-47700)[11] |
9821 | Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)[12] |
9834 | N-(1-Phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl)[13] |
7034 | 2-(1-(5-Fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB, 5F-MDMB-PINACA)[14] |
7033 | Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB)[14] |
7049 | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA, 5F-AKB48)[14] |
7010 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA)[14] |
7042 | Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA, MMB-CHMINACA)[14] |
7020 | Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA)[14] |
9811 | Acryl fentanyl ((N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide); Acryloylfentanyl)[15] |
9816 | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (Ortho-fluorofentanyl or 2-fluorofentanyl)[16] |
9822 | Butyryl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)[17] |
9824 | 4-Fluoroisobutyryl fentanyl ((N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) or Para-fluoroisobutyryl fentanyl)[18] |
9825 | 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (Methoxyacetyl fentanyl)[16] |
9836 | Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide)[17] |
9843 | N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (Tetrahydrofuranyl fentanyl)[16] |
9845 | (1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl)[19] |
7032 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)[20] |
9840 | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl)[21] |
9823 | N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl)[21] |
9837 | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl)[21] |
9826 | N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl)[21] |
9827 | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl)[21] |
9847 | N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl)[21] |
9838 | N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil)[21] |
9850 | Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers[22] |
References[edit]
- ^ ab21 CFR1308.11 (CSA Sched I) with changes through 77 FR64032 (Oct 18, 2012). Retrieved September 6, 2013.
- ^21 U.S.C.§ 812(b)(1)United States Code via Cornell University's Legal Information Institute. Retrieved on 2007-10-02.
- ^Drug Enforcement Administration (DEA) (22 Jan 2002). 'Title 21 — Food and Drugs Chapter 13 - Drug Abuse Prevention and Control Subchapter I — Control and Enforcement Part D — Offenses and Penalties: Sec. 841. Prohibited Acts A(a)'. Retrieved 23 Oct 2009.
- ^Drug Enforcement Administration, Department of Justice (2017). 'Schedules of Controlled Substances: Placement of Acetyl Fentanyl into Schedule I. Final order'. Federal Register. 82 (108): 26349–51. PMID28591974.
- ^https://www.gpo.gov/fdsys/pkg/FR-2016-12-14/pdf/2016-29941.pdf
- ^Code of Federal Regulations, 2012-04-01
- ^The first 8 items in the temporary section of the schedule shown on the DEA website are not included here because they are duplicates of entries in the tables above. Presumably, this is because they were made permanent and copied there at some point, but inadvertently not deleted from this temporary listing section.
- ^ abcdDrug Enforcement Administration, Department of Justice (Feb 10, 2014). 'Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order'. Fed. Regist. 79 (27): 7577–7582. PMID24605391.
- ^ abcDrug Enforcement Administration, Department of Justice (2015). 'Schedules of controlled substances: Temporary placement of three synthetic cannabinoids into schedule I. Final order'. Federal Register. 80 (20): 5042–7. PMID25730924.
- ^ abcDrug Enforcement Administration (2015). 'Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order'. Fed. Regist. 80 (219): 70657–9. PMID26567439.
- ^'DEA Schedules Deadly Synthetic Drug U-47700'. November 10, 2016.
- ^Drug Enforcement Administration (2015). 'Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl Into Schedule I. Final order'. Fed. Regist. 80 (137): 42381–5. PMID26189217.
- ^Drug Enforcement Administration, Department of Justice (2016). 'Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl Into Schedule I. Final order'. Fed. Regist. 81 (229): 85873–7. PMID27906535.
- ^ abcdef'Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I'. Drug Enforcement Administration.
- ^Drug Enforcement Administration, Department of Justice (2017). 'Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl into Schedule I. Temporary scheduling order'. Federal Register. 82 (134): 32453–7. PMID28715161.
- ^ abcDrug Enforcement Administration, Department of Justice (2017). 'Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl into Schedule I. Temporary amendment; temporary scheduling order'. Federal Register. 82 (206): 49504–8. PMID29091366.
- ^ abDrug Enforcement Administration, Department of Justice (2016). 'Schedules of Controlled Substances: Temporary Placement of Butyryl Fentanyl and Beta-Hydroxythiofentanyl into Schedule I. Final order'. Federal Register. 81 (92): 29492–6. PMID27192733.
- ^Drug Enforcement Administration, Department of Justice (2017). 'Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I. Temporary scheduling order'. Federal Register. 82 (84): 20544–8. PMID28497944.
- ^Drug Enforcement Administration, Department of Justice (2018). 'Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl in Schedule I. Temporary amendment; temporary scheduling order'. Federal Register. 83 (3): 469–72. PMID29319947.
- ^Drug Enforcement Administration, Department of Justice (2018). 'Schedules of Controlled Substances: Extension of Temporary Placement of MAB–CHMINACA in Schedule I of the Controlled Substances Act. Temporary rule; temporary scheduling order; extension'. Federal Register. 83 (20): 4411–2. PMID29461023.
- ^ abcdefgDrug Enforcement Administration, Department of Justice (2018). 'Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order'. Federal Register. 83 (22): 4580–5. PMID29932604.
- ^Drug Enforecement Administration, Department of Justice (2018). 'Schedules of Controlled Substances:Temporary Placement of Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order'. Federal Register. 83 (25): 5188–92. PMID29932611.
This is the list of Schedule III drugs as defined by the United StatesControlled Substances Act at 21 U.S.C.§ 812(c) and 21 C.F.R.1308.13, with modifications through August 22, 2014 (79 FR49961). The following findings are required for drugs to be placed in this schedule:[1]
- The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
- The drug or other substance has a currently accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The complete list of Schedule III drugs follows. The Administrative Controlled Substances Code Number for each drug is included.
Stimulants[edit]
ACSCN | Drug |
---|---|
1405 | See 21 CFR1308.13(b)(1) |
1228 | Benzphetamine |
1645 | Chlorphentermine |
1647 | Clortermine |
1615 | Phendimetrazine |
Depressants[edit]
ACSCN | Drug |
---|---|
2126 | Amobarbital |
2100 | Any derivative of Barbituric acid |
2510 | Chlorhexadol |
2020 | Embutramide |
2012 | Xyrem (sodium oxybate) oral solution[2] |
2261 | Perampanel[3] |
7285 | Ketamine |
2575 | Methyprylon |
2600 | Sulfondiethylmethane |
2605 | Sulfonethylmethane |
2610 | Sulfonmethane |
7295 | Tiletamine and zolazepam |
7369 | Dronabinol in sesame oil and encapsulated in a soft gelatin capsule |
Others[edit]
ACSCN | Drug |
---|---|
9400 | Nalorphine |
Narcotics[edit]
ACSCN | Drug |
---|---|
9803 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium |
9804 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9807 | Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts |
9808 | Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9809 | Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9810 | Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9064 | Buprenorphine |
Steroids[edit]
ACSCN | Drug |
---|---|
4000 | Anabolic steroids |
Hallucinogens[edit]
ACSCN | Drug |
---|---|
7300 | Lysergic acid |
7310 | Lysergic acid amide |
References[edit]
- ^21 U.S.C.§ 812(b)(3) retrieved September 3, 2014
- ^'Xyrem® (sodium oxybate) Oral Solution CIII. Prescribing information. Revised: December 2012'(PDF). Archived from the original(PDF) on 2013-02-03.
- ^'Department of Justice. Drug Enforcement Administration. Schedules of Controlled Substances: Placement of Perampanel into Schedule III'(PDF). Federal Register. Office of the Federal Register, National Archives and Records Administration. 78 (204): 62500–62506. October 22, 2013. Retrieved 22 February 2014.